|
|
Post by nylefty on Dec 7, 2019 16:36:35 GMT -5
Bill has a serious conflict of interest by owning a business that solely relies on Afrezza. Not sure how this is even legal let alone ethical to allow him to be on the board? Perhaps one of the PB attorneys can chime in? I’m curious as well. Bill has a law degree (and a MBA) so I'm sure he's thought about this issue. Here's a quote from an article about this subject: A conflict of interest is not necessarily bad, especially when the interested board member is motivated by a desire to help the corporation. However, full and complete disclosure of the conflict prevents board members from acting strictly out of their own self-interest. smallbusiness.chron.com/conflict-interest-board-directors-74978.html
|
|
|
|
Post by ktim on Dec 7, 2019 17:04:21 GMT -5
Yeah Bill has a bad habit.. he starts off telling people the truth, and then he keeps telling them the truth. And sometimes it hurts, and sometimes it’s hard to get your mind around what you thought could happen just isn’t happening. So it’s just easier to hate Bill:-) I think you’ll like though his coming ideas of what’s possible. He understands the medical community extremely well. Their unwillingness to prescribe. A doctors they hired to work in one of the clinics had a bunch of samples on a shelf that he’d never even looked at. Never bothered. They put the doctors through training until their lights go on, and then it’s ...Holy moly! If the doctor doesn’t understand it why would he bother to prescribe it? Especially when it takes so much more time and effort to get the person to realize the potential of the benefits and results they could have. Education equals retention. Time with the patient equals retention. Really caring about the patient is everything. I certainly don't doubt what you say, though I would suspect MNKD management also knows the medical community extremely well. I'm sure MNKD is trying to get the FDA to allow updating of the prescribing lit to reflect better methods of titration and dosing, but until that happens MNKD is limited to educating docs about what is in the prescribing lit. And time with patients and really caring aren't things MNKD has much influence to change with doctors. The time with patients in my understanding is mainly a reimbursement issue. I've seen articles in the past where diabetes clinics trying to operate with more attentive and holistic approach to diabetes management have shut down due to insurers not covering the more intensive interaction with patients. So the question I'd have is given you've listed these as crucial things, that you apparently feel VDex is doing right and others aren't. What is it that HFM is proposing that MNKD do in order to address these differently with the broader community of docs? If someone is going to be on the BOD and presenting ideas for MNKD, they need to be ideas to address all the market. Obviously MNKD can't ignore all the non-VDex endos and GPs. |
|
|
|
Post by sportsrancho on Dec 7, 2019 18:03:54 GMT -5
Vdex doesn’t have the insurance issues of other clinics because they use results to get the coverage. We all know how good those results with Afrezza are. That’s what they do and they do it well.
mnholdem can give some ideas on what you mentioned. I believe he said he would in the coming days or weeks.
|
|
|
|
Post by ktim on Dec 7, 2019 18:20:28 GMT -5
Vdex doesn’t have the insurance issues of other clinics because they use results to get the coverage. We all know how good those results with Afrezza are. That’s what they do and they do it well. mnholdem can give some ideas on what you mentioned. I believe he said he would in the coming days or weeks. Wonder if something has changed with insurers since this article titled "In the Treatment of Diabetes, Success Often Does Not Pay". It has been a long time. www.nytimes.com/2006/01/11/nyregion/nyregionspecial5/11diabetes.htmlWould be nice to think insurers would pay for better outcomes. Guess I've read enough anecdotal stories of people losing coverage despite having great results with Afrezza to believe this isn't still a problem. But great if VDex has figured out how to turn a profit while still providing intensive patient support. |
|
|
|
Post by mytakeonit on Dec 7, 2019 20:31:04 GMT -5
Well even a newspaper filled with news ... has a comics page.
But, that's mytakeonit
|
|
|
|
Post by akemp3000 on Dec 7, 2019 21:04:46 GMT -5
I'm also in the camp that believes MC has done an excellent job turning this company around in a short period of time. The future was not looking as bright a year or two ago. It is now and the next year should bring pediatric approval, new TS applications, continued Afrezza script growth and foreign sales. Granted the pps currently sucks but that turn around should follow soon. I like Bill and wish VDex the best of success but don't believe any outsider has earned a position on Mannkind's board. It's easy to complain and say change is needed but change can do more damage than good. IMO MC has this company on a good path. I realize Bill and some others don't agree and that's fine. I'm also of the opinion this discussion will soon become an insignificant footnote in history as its difficult to believe any proposed changes to the board will reach the threshold needed to succeed. Good luck to all longs no matter the varying perspectives!
|
|
|
|
Post by mytakeonit on Dec 7, 2019 23:31:23 GMT -5
No, I am of the belief that this train of thought needs to continue.  Well, at least till my $$$ comes in. But, that's mytakeonit |
|
Well, at least till my $$$ comes in.